Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Alterations in Spiking Following Muscle Fatigue in Volleyball Players

1 juillet 2026 mis à jour par: National Yang Ming Chiao Tung University

Alterations in Spiking Kinematic, Muscle Activation, and Subacromial Structures Following Muscle Fatigue in Volleyball Players

This study aims (1)to investigate the effects of repetitive functional overhead movements targeting shoulder and scapular muscles on glenohumeral and scapular kinematics and muscle activation during the arm cocking and acceleration of spiking, and changes in subacromial structures in healthy recreational volleyball players; (2) to compare these fatigue-related changes between athletes with good and poor shoulder motor control.

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Type d'étude

Observationnel

Inscription (Estimé)

35

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

      • Taipei, Taïwan, 112
        • National Yang Ming Chiao Tung University
        • Contact:
          • National Yang Ming Chiao Tung University
          • Numéro de téléphone: (02)2826-7049
          • E-mail: tshuang@nycu.edu.tw

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Oui

Méthode d'échantillonnage

Échantillon de probabilité

Population étudiée

Healthy recreational volleyball players

La description

Inclusion Criteria:

  • Between 18 and 35 years old
  • At least 2 consecutive years of volleyball experience
  • Involved in volleyball practice or game for at least 4 hours per week
  • Able to perform a cross-body spike with 3-step

Exclusion Criteria:

  • A history of major shoulder or spinal injury or surgery
  • Experiencing shoulder pain (VAS ≥ 3/10) in the last 6 months

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Poor shoulder motor control
During shoulder medial rotation up to 60° in supine position, the scapula forward tilts or elevation occurs, difficulties in breathing, performing difficulties, unable to perform 60° medial rotation, glenohumeral anterior translation, fatigue, the need of external feedback and external support.

The subject performed upper extremity D2 diagonal exercise with Thera-band at kneeling position to simulate the arm movement of a volleyball spike. The movement is paced by a metronome at one beat per second, with one movement per beat. If participants could not keep up or become too fatigued, they are allowed to rest for 15 seconds before continuing.

The subject was defined as fatigued, and the fatigue activity was stopped, only when all three of the following cumulative conditions were met:

  1. Until the number of repetitions in that set was less than 50% of the repetitions performed in the first set.
  2. Using the Rating of Perceived Exertion (RPE) on a 6-20 scale, until the subject's RPE was greater than or equal to 15.
  3. If this maximum strength showed a decrease of 25% or more compared to the maximum strength measured before the fatigue activity.
Good shoulder motor control
During shoulder medial rotation up to 60° in supine position, no scapula and glenohumeral compensation, easy to breathing and perform 60° medial rotation without external feedback and external support.

The subject performed upper extremity D2 diagonal exercise with Thera-band at kneeling position to simulate the arm movement of a volleyball spike. The movement is paced by a metronome at one beat per second, with one movement per beat. If participants could not keep up or become too fatigued, they are allowed to rest for 15 seconds before continuing.

The subject was defined as fatigued, and the fatigue activity was stopped, only when all three of the following cumulative conditions were met:

  1. Until the number of repetitions in that set was less than 50% of the repetitions performed in the first set.
  2. Using the Rating of Perceived Exertion (RPE) on a 6-20 scale, until the subject's RPE was greater than or equal to 15.
  3. If this maximum strength showed a decrease of 25% or more compared to the maximum strength measured before the fatigue activity.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Degree of the glenohumeral and scapulothoracic joint during spiking
Délai: Baseline, immediately post-intervention (Day 1)

The kinematics is assessed using an electromagnetic motion tracking system (VIPERTM, Polhemus, USA) to measure the glenohumeral elevation, horizontal abduction/adduction, internal/external rotation, and scapulothoracic retraction/protraction, upward/downward rotation, anterior/posterior tilt during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial.

Data were collected at the end of the arm cocking (maximal shoulder horizontal abduction) and at ball-contact (maximal footswitch signal), and reported as mean values for each trial. (unit of measure: degree, °)

Baseline, immediately post-intervention (Day 1)
Activation amplitude of the glenohumeral and periscapular muscles
Délai: Baseline, immediately post-intervention (Day 1)

The muscle activation amplitude of the serratus anterior, upper trapezius, lower trapezius, middle deltoid, infraspinatus, and pectoralis major during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial.

Data were collected in the arm cocking phase (from minimal shoulder elevation to the shoulder maximal horizontal abduction) and the acceleration phase (from maximal shoulder horizontal abduction to the ball-contact), and reported as mean values for each trial. (unit of measure: percentage, %)

Baseline, immediately post-intervention (Day 1)
Mean power frequency of the glenohumeral and periscapular muscles
Délai: Baseline, immediately post-intervention (Day 1)

The mean power frequency of the serratus anterior, upper trapezius, lower trapezius, middle deltoid, infraspinatus, and pectoralis major during spiking movement. During the test, participants performed 3 times of cross-body spikes, with 15 seconds of rest between each trial.

Data were collected in the arm cocking phase (from minimal shoulder elevation to the shoulder maximal horizontal abduction) and the acceleration phase (from maximal shoulder horizontal abduction to the ball-contact), and reported as mean values for each trial. (unit of measure: hertz, Hz)

Baseline, immediately post-intervention (Day 1)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Acromio-humeral distance and thickness of supraspinatus tendon thickness during arm elevation
Délai: Baseline, immediately post-intervention (Day 1)

The subacromial structures is assessed using a diagnostic ultrasound system (SONIMAGE MX1 Ver. 1.10, Konica Minolta, Inc., Tokyo, Japan) to measure the acromio-humeral distance (AHD, from the lateral inferior edge of the acromion perpendicular to the humerus), supraspinatus tendon thickness (SST, from the subacromial-subdeltoid bursa perpendicular to the humerus), occupation ratio (OR, dividing SST by AHD). During the dynamic evaluation, participants performed 3 times of arm elevation to 90° and returning to the neutral position at scapular plane. During the static evaluation, participants performed 3 times of arm elevation to 60° at scapular plane.

Data of dynamic evaluation is collected at 0° elevation and at the greater tuberosity of the humerus is aligned under the lateral inferior edge of the acromion. Data of static evaluation is collected at 0° elevation and 60° elevation. Data reported as mean values for each trial. (unit of measure: millimeter, mm)

Baseline, immediately post-intervention (Day 1)
Degree of shoulder elevation at greater tuberosity-acromion alignment during arm elevation
Délai: Baseline, immediately post-intervention (Day 1)
The shoulder elevation angle is measured using a application software (Measure, Apple Inc., USA) at at greater tuberosity of humerus under Lateral inferior edge of the acromion, which assess diagnostic ultrasound system (SONIMAGE MX1 Ver. 1.10, Konica Minolta, Inc., Tokyo, Japan), and reported as mean values for each trial. (unit of measure: degree, °).
Baseline, immediately post-intervention (Day 1)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 juillet 2026

Achèvement primaire (Estimé)

1 janvier 2027

Achèvement de l'étude (Estimé)

1 janvier 2027

Dates d'inscription aux études

Première soumission

17 décembre 2025

Première soumission répondant aux critères de contrôle qualité

1 juillet 2026

Première publication (Réel)

7 juillet 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

7 juillet 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

1 juillet 2026

Dernière vérification

1 novembre 2025

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • NYCU114118AF

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner